Pharma-Bio Serv Q1 revenue rises to $5.0M; net income flat at $0.3M

Pharma-Bio Serv, Inc.

Revenue of $5.0M, up ~$0.5M YoY; net income unchanged at ~$0.3M.
US and Europe consulting revenue grew to 33% of total, up from 22% YoY.
CEO cites geographic diversification as key to future growth and risk reduction.
No revised guidance or other material operational changes reported.

item 2.02 item 9.01

Pharma-Bio Serv, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-22-003384

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.